Chinese PLA General Hospital: all 568 studies

Page 6 of 6. Open to participants first (205), then studies with results posted, then the rest; newest registration first within each.

• Icotinib as the Adjunctive Treatment After Surgery in Stage I-IIIB Lung Adenocarcinoma Patients With EGFR Gene MutationStatus unknownNCT02283424Phase 4
• T- XELOX in HER2-positive Stage III Gastric Cancer After D2 GastrectomyStatus unknownNCT02250209Phase 2
• Efficacy and Safety of Abelmoschus Manihot for Chronic Kidney DiseaseStatus unknownNCT02231138Phase 4
• Influences of Phenylephrine, Dopamine and Ephedrine on Stroke Volume Variation and Pulse Pressure VariationCompletedNCT02201121Not applicable
• Dynamic Changes of Tim-3 on Monocytes and Soluble Tim-3 in Patients With SepsisCompletedNCT02180009
• Lower Dose Decitabine (DAC)-Primed TC (Carboplatin-Paclitaxel) Regimen in Ovary CancerStatus unknownNCT02159820Phase 2/3
• Nab-paclitaxel Plus Gemcitabine in Chinese Patients With Advanced Pancreatic CancerStatus unknownNCT02135822Phase 2
• Nab-paclitaxel Plus S-1 in Patients With Advanced Pancreatic CancerStatus unknownNCT02124317Phase 2
• Fish Oil and Cardiovascular Suboptimal HealthCompletedNCT02103517Phase 3
• CART-19 Immunotherapy in Mantle Cell LymphomaStatus unknownNCT02081937Phase 1/2
• Efficacy and Safety of Shenyankangfu Tablets for Primary GlomerulonephritisStatus unknownNCT02063100Phase 4
• Neoadjuvant Bev Plus DOF vs DOF in LAGC and Its Association With Circulating Tumor CellCompletedNCT02048540Phase 1/2
• Genotyping Guided Individualized Treatment of Clopidogrel and Ticagrelor in ACSStatus unknownNCT02048228Phase 2/3
• After Induction Chemotherapy of DP Plus DDP Concurrent Radiotherapy With and Without Bevacizumab StudyStatus unknownNCT02047487
• Clopidogrel Pharmacogenetic Score SystemStatus unknownNCT01990989
• Treatment of Chemotherapy Refractory Human Epidermalgrowth Factor Receptor-2( HER-2) Positive Advanced Solid TumorsStatus unknownNCT01935843Phase 1/2
• Study on the Model of Smoking Cessation Intervention and Service Ability ImprovementStatus unknownNCT01935505
• Postoperative Recovery in Elderly Patients Undergoing Hip Hemi-arthroplastyStatus unknownNCT01934049Phase 4
• Identification Sepsis Related Single Nucleotide Polymorphism (SNP) by Whole Exome SequencingStatus unknownNCT01920217
• Temozolomide as Maintenance Therapy in Small Cell Lung CancerStatus unknownNCT01900951Phase 2
• Autologous Cytokine Induced Killer Cells (CIK) for Patients With Severe PsoriasisCompletedNCT01894373Phase 1/2
• Treatment of Chemotherapy Refractory Multiple Myeloma by CART-138Status unknownNCT01886976Phase 1/2
• The Assessment of Postoperative Recovery in Elder Diabetic PatientsStatus unknownNCT01871012
• Treatment of Chemotherapy Refractory EGFR(Epidermal Growth Factor Receptor) Positive Advanced Solid Tumors (CART-EGFR)Status unknownNCT01869166Phase 1/2
• Treatment of Relapsed and/or Chemotherapy Refractory CD33 Positive Acute Myeloid Leukemia by CART-33Status unknownNCT01864902Phase 1/2
• Treatment of Relapsed and/or Chemotherapy Refractory B-cell Malignancy by CART19Status unknownNCT01864889Not applicable
• Clinical Study in Treatment of Malignant Ascites of Ovarian Cancer With Intraperitoneal Injection Bevacizumab Combined With Intraperitoneal Hyperthermic Perfusion ChemotherapyStatus unknownNCT01838538Phase 2
• Alpha-1-acid Glycoprotein as a Biomarker of Developmental Diagnosing and Monitoring Effectiveness in SepsisStatus unknownNCT01838525
• Amino Acids Expression Profiling of Patients With SepsisStatus unknownNCT01818830
• Combination Iodine 125 Seed Implants and LHRH Agonists for Locally Advanced (Stage T3) Prostate CancerCompletedNCT01813097
• The Prognostic Assessment of Extubation in Aged Patients With Multiple Organ Dysfunction SyndromeStatus unknownNCT01802983
• Autologous Natural Killer T Cells Infusion for the Treatment of CancerStatus unknownNCT01801852Not applicable
• Detection Of Monocytes/Macrophages Function And Tim-3 Expression In Septic PatientsCompletedNCT01801839
• Safety and Effectiveness Evaluation of Two Kinds of Peritoneal DialysateCompletedNCT01779557Phase 4
• Decitabine Followed by Donor Lymphocyte Infusion for Patients With Relapsed Acute Myeloblastic Leukemia(AML) After Allogeneic Stem Cell TransplantationStatus unknownNCT01758367Phase 1/2
• Elecsys HE4 Chinese Reference Value StudyCompletedNCT01738269
• Genetically Engineered Lymphocyte Therapy in Treating Patients With Lymphoma That is Resistant or Refractory to ChemotherapyStatus unknownNCT01735604Phase 1/2
• Piperacillin/Tazobactam for Empirical Therapy of Febrile NeutropeniaCompletedNCT01714570Not applicable
• Prophylactic Piperacillin/Tazobactam in Hematopoietic Stem Cell TransplantationStatus unknownNCT01714557Not applicable
• Decitabine Combining Modified CAG Followed by HLA Haploidentical Peripheral Blood Mononuclear Cells Infusion for Elderly Patients With Acute Myeloid Leukemia(AML）CompletedNCT01690507Phase 1/2
• Sepsis MetabolomicsCompletedNCT01649440
• Vitamin D and Critically Ill PatientsCompletedNCT01636232
• Applying Pharmacogenetics to Warfarin Dosing in Chinese PatientsStatus unknownNCT01610141Phase 4
• Association Between cd163 Gene Polymorphisms and Sepsis Among Chinese Han PopulationStatus unknownNCT01504243
• The Changes of CD4+T Lymphocyte Subsets in Septic PatientsStatus unknownNCT01494389
• Urinary Proteomics Analysis for Sepsis and PrognosisStatus unknownNCT01493492
• Serum Proteomics Analysis for SepsisStatus unknownNCT01493466
• TREM-1 Gene PolymorphismsCompletedNCT01490424
• MiRNAs Evaluate the Prognosis of Sepsis by Dynamic StudyStatus unknownNCT01459822
• The Value of sTREM-1, PCT, and CRP as Markers for the Detection of Sepsis and Bacteremia Among Patients With a FUOCompletedNCT01410578
• Diagnostic Value of sTREM-1 and PCT Level as Well as CPIS Score for Ventilator-Associated Pneumonia Among ICU Sepsis PatientsCompletedNCT01406951
• Perfluorocarbon (PFC) Inhalation Treatment of Acute Lung Injury/Acute Respiratory Distress SyndromeStatus unknownNCT01391481Phase 2
• Comparison the Value of Several Biomarkers of SepsisCompletedNCT01388725
• Endoscopic Submucosal Dissection for Gastrointestinal NeoplasmsStatus unknownNCT01378507Not applicable
• The Application of Soluble Triggering Receptor Expressed on Myeloid Cells-1 in Sepsis & Relevant Acute Kidney InjuriesCompletedNCT01333657
• Vitamin B6 on Relieving Linezolid-associated CytopeniasStatus unknownNCT01295801
• Ulinastatin in Inhalation Lung InjuryStatus unknownNCT01287806Phase 2
• Cell Therapy in Patients With Chronic Ischemic Heart Disease Undergoing Cardiac SurgeryStatus unknownNCT01267331Phase 1/2
• MiRNAs Evaluate the Prognosis of SepsisStatus unknownNCT01207531
• Confocal Laser Endomicroscopy in Digestive DiseasesStatus unknownNCT01156064
• A Chinese Randomized Crossover Study of Erlotinib Versus Docetaxel/Cisplatin in Previously Untreated Stage IIIB/IV Lung Adenocarcinoma With EGFR MutationsStatus unknownNCT01131429Phase 2
• Study of S-1 and Oxaliplatin as Neoadjuvant Chemotherapy for Locally Advanced Gastric CancerStatus unknownNCT01090505Phase 2
• Abnormal Expression Proteins, Mitochondrial DNA and miRNA of Irritable Bowel SyndromeStatus unknownNCT01028898
• Optical Coherence TomOgraphy Assessment of the Drug-Eluting StentStatus unknownNCT01012583
• Application of Computer-assisted Navigation in Total Knee Arthroplasty: A Randomized Pair-matched Double-blind TrialCompletedNCT00982956
• A Safety Comparison of Iopromide and Iodixanol in Renal Impaired PatientsCompletedNCT00926562Phase 4
• Rosuvastatin Evaluation of Atherosclerotic Chinese Patients (REACH)Status unknownNCT00885872Phase 4
• Comparison of the Effects of Repaglinide and Metformin on Glucose ExcursionsStatus unknownNCT00832481Not applicable

← Chinese PLA General Hospital overview and focus areas